HDDAH-1-IN-2
HDDAH-1-IN-2 is a selective, orally active human dimethylarginine dimethylaminohydrolase-1 (hDDAH-1) inhibitor. hDDAH-1-IN-2 reveals an excellent profile regarding cell toxicity/viability[1].
Product Specifications
CAS Number
2408834-77-3
UNSPSC
12352211
Target
Drug Intermediate
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Neurological Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/hddah-1-in-2.html
Solubility
10 mM in DMSO
Smiles
NCCCCNC(NCCOC)=NO
Molecular Formula
C8H20N4O2
Molecular Weight
204.27
References & Citations
[1]Lunk I, et al. Discovery of N- (4-Aminobutyl) -N'- (2-methoxyethyl) guanidine as the First Selective, Nonamino Acid, Catalytic Site Inhibitor of Human Dimethylarginine Dimethylaminohydrolase-1 (hDDAH-1) .J Med Chem. 2020 Jan 9;63 (1) :425-432.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC211899L4V 200 µL
PPEF2 (NM_006239) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
MBS9236660-02 5x 0.1 mL
LY6E/Stem cell antigen 1 Polyclonal Antibody
Sign In for Pricing
View Details T8051-06-ML490 100 µL
TLR10 (Toll Like Receptor 10, CD290) (MaxLight 490)
Sign In for Pricing
View Details 
K3148407 1.0 µg DNA
Clic3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details